Investor Presentation: First Nine Months of 2020
105
Investor presentation
First nine months of 2020
Insulin market size and volume market share in
North America Operations
Total
Insulin market share and market size (DKK billion)
Long-
acting
39%
43%
Fast-
51%
77
acting
58%
Premix
10
106
29%
Human
16
Novo Nordisk
Competitors
Note: Insulin market numbers do not reflect rebates. See slide 97.
Novo Nordisk®
Market
growth
A Market
share
Insulin volume: market share
60%
10%
210
1%
+0.1%
8%
50%
40%
6%
3%
-0.2%
40%
4%
30%
2%
-0.8%
+1.3%
0%
20%
0%
10%
-9%
-0.8%
0%
Aug
2017
-2%
-4%
Aug
2020
2%
-0.9%
Source: IQVIA, Aug 2020, LHS graph - Value, RHS Graph - Volume, MAT, all countries. Share of growth not depicted due to too high numbers; NN: Novo Nordisk
-NN market share
-Market growth (right axis)
NN growth (right axis)View entire presentation